SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

03 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 1003.16 millions grew by 16.62 % from Rs. 860.20 millions.The company has announced a 49.86% increase in its profits to Rs . 65.70  millions for the  quarter ended December 2022 compared to Rs. 43.84 millions in the corresponding quarter in the previous year.Operating profit surged to 150.60 millions from the corresponding previous quarter of 113.61 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1003.16 860.20 16.62 2920.83 2253.86 29.59 3294.94 3036.29 8.52
Other Income 24.21 7.21 235.78 57.32 28.59 100.49 45.06 24.49 83.99
PBIDT 150.60 113.61 32.56 418.71 271.12 54.44 424.40 392.62 8.09
Interest 16.16 17.50 -7.66 43.05 68.75 -37.38 83.06 108.86 -23.70
PBDT 134.44 96.11 39.88 375.66 202.37 85.63 341.34 231.95 47.16
Depreciation 35.57 35.31 0.74 115.51 109.60 5.39 148.37 146.14 1.53
PBT 98.87 60.80 62.62 260.15 92.77 180.42 192.97 85.81 124.88
TAX 33.17 16.96 95.58 81.47 27.05 201.18 62.84 29.64 112.01
Deferred Tax 14.81 6.99 111.87 34.87 12.23 185.12 28.84 29.47 -2.14
PAT 65.70 43.84 49.86 178.68 65.72 171.88 130.13 56.17 131.67
Equity 487.26 162.42 200.00 487.26 162.42 200.00 162.42 162.42 0.00
PBIDTM(%) 15.01 13.21 13.67 14.34 12.03 19.17 12.88 12.93 -0.39

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×